8-K - KALA BIO, Inc. | StockGist

Current Report Details

Event Type

Management Change+4 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

of this Current Report on Form 8-K regarding the Officer Settlement Agreements is incorporated by reference into this Item 5.02. Resignation of Director On Nove

Material Agreement

Source Document

1.02

. 4 Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained in I

Material Agreement

Source Document

2.03

. Item 3.02. Unregistered Sales of Equity Securities. The information contained in Item 1.01 of this Current Report on Form 8-K and the information contained in

Financing

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Termination

Management Change

Chief Executive Officer and a director of the

5.03

. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On November 24, 2025 (the “Filing Date”), the Company filed a Certificate of Designa

Charter Amendment

$2.00

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Designations, Preferences and Rights of Series AA Convertible Non

Exhibits Only

Exhibits (7)

10.1

EXHIBIT 10.1

10.2

EXHIBIT 10.2

10.3

EXHIBIT 10.3

10.4

EXHIBIT 10.4

3.1

EXHIBIT 3.1

4.1

EXHIBIT 4.1

8-K